Merck & Co MRK reported higher-than-expected first-quarter earnings, fueled by strong sales of its drugs for diabetes, asthma and rheumatoid arthritis. Merck & Co said it earned $1.04 billion, or 34 cents per share. That compared with $299 million, or 9 cents per share, a year earlier. More information about the GDP report can be found here.
D.R. Horton DHI reported a surprise quarterly profit on Friday, helped by a tax benefit. Horton posted earnings of $27.8 million, or 9 cents per share, for the second quarter ended March 31, up from $11.4 million, or 4 cents per share, a year earlier. More information can be found here.
Simon Property Group SPG saw first-quarter funds from operations rise on greater occupancy and sales at its malls and outlet centers. Simon posted quarterly funds from operations of $570.6 million, or $1.61 per share, compared with $325.6 million, or 94 cents per share, a year earlier. More information can be found here.
Also, U.S. health insurer Coventry Health Care CVH posted better-than-expected quarterly earnings, helped by higher membership, and raised its 2011 view. For the full year, it now expects earnings of $2.65-$2.85 a share on revenue of $11.67-$12.09 billion. More information can be found here.
Kohlberg Kravis Roberts & Co KKR is in talks to buy Singapore-listed abalone farmer Oceanus Group Ltd in a deal that may be worth around $500 million, three sources with direct knowledge of the matter told Reuters. Private equity firm KKR has lined up financing of $300-400 million from a group of banks, according to one of the sources. More information can be found here.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: EarningsNewsGuidanceFinancingHedge FundsM&AGlobalPre-Market OutlookIntraday UpdateMarketsConsumer DiscretionaryFinancialsHealth CareHomebuildingManaged Health CarePharmaceuticalsRetail REIT's
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in